According to Trendlyne shareholding data, retail investors held a 50.2% stake in the company as of Q3FY25, up from 47.4% in the same period last year. Over this period, the retail investor base ...
Dyne Therapeutics Inc. 4.43% $1.38B ...
Fully functional Open Source email marketing manager for creating, sending, integrating, and analysing email campaigns and newsletters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback